US Stock MarketDetailed Quotes

RENB Renovaro

Watchlist
  • 0.822
  • -0.072-8.02%
Trading Mar 4 12:32 ET
130.47MMarket Cap-1.05P/E (TTM)

About Renovaro Company

Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Company Profile

SymbolRENB
Company NameRenovaro
Listing DateDec 10, 2018
Founded2011
CEOMr. David Weinstein
MarketNASDAQ
Employees25
Fiscal Year Ends06-30
Address2080 Century Park East,Suite 906
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90067
Phone1-305-918-1980
Websitehttp://renovarobio.com

Company Executives

  • Name
  • Position
  • Salary
  • Maurice van Tilburg
  • Director; Chief Executive Officer, GEDi Cube B.V
  • --
  • David Weinstein
  • Chief Executive Officer and Director
  • --
  • Nathen Fuentes, C.P.A.
  • Chief Financial Officer
  • --
  • James A. Mcnulty, C.P.A.
  • Director
  • --
  • Douglas W. Calder
  • Director
  • --
  • Dr. Mark A. Collins, PhD
  • Director
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Jiangsu Changyou Environmental Protection Technology
301557
+211.60%
Hefei conver Holding
603409
+110.13%
LIERDA
832149
+30.00%
4
SHENGNAN TECHNOLOGY
837006
+29.98%
5
CHK
831167
+29.97%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
As China's 'two sessions' approach: How will Chinese stocks perform?
🎙️Discussion 1. With China's 'two sessions' approaching, do you focus more on policy dynamics or capital flows? 2. Which industry sectors d Show More
Chinese Stocks' Wild Rally Hits Pause? Wall Street Still Bets Big on Favorites